Published in Invest Radiol on March 01, 2002
Efficient magnetic cell labeling with protamine sulfate complexed to ferumoxides for cellular MRI. Blood (2004) 4.66
Human mesenchymal stem cells exert potent antitumorigenic effects in a model of Kaposi's sarcoma. J Exp Med (2006) 3.81
Characterization of biophysical and metabolic properties of cells labeled with superparamagnetic iron oxide nanoparticles and transfection agent for cellular MR imaging. Radiology (2003) 3.72
Humanized anti-CD25 (daclizumab) inhibits disease activity in multiple sclerosis patients failing to respond to interferon beta. Proc Natl Acad Sci U S A (2004) 2.37
Measurement of atrophy in multiple sclerosis: pathological basis, methodological aspects and clinical relevance. Brain (2002) 2.30
A model of lysosomal metabolism of dextran coated superparamagnetic iron oxide (SPIO) nanoparticles: implications for cellular magnetic resonance imaging. NMR Biomed (2005) 2.20
MRI of tumor angiogenesis. J Magn Reson Imaging (2007) 2.19
Labeling of cells with ferumoxides-protamine sulfate complexes does not inhibit function or differentiation capacity of hematopoietic or mesenchymal stem cells. NMR Biomed (2005) 2.02
In vivo magnetic resonance tracking of magnetically labeled cells after transplantation. J Cereb Blood Flow Metab (2002) 1.99
Detection and quantification of magnetically labeled cells by cellular MRI. Eur J Radiol (2008) 1.87
Noninvasive MR imaging of magnetically labeled stem cells to directly identify neovasculature in a glioma model. Blood (2004) 1.76
Cellular magnetic resonance imaging: current status and future prospects. Expert Rev Med Devices (2006) 1.71
Magnetic resonance imaging and confocal microscopy studies of magnetically labeled endothelial progenitor cells trafficking to sites of tumor angiogenesis. Stem Cells (2005) 1.61
In vivo trafficking and targeted delivery of magnetically labeled stem cells. Hum Gene Ther (2004) 1.61
Effects of interferon beta-1b on black holes in multiple sclerosis over a 6-year period with monthly evaluations. Arch Neurol (2005) 1.60
Expression of transferrin receptor and ferritin following ferumoxides-protamine sulfate labeling of cells: implications for cellular magnetic resonance imaging. NMR Biomed (2006) 1.58
Heterogeneity in response to interferon beta in patients with multiple sclerosis: a 3-year monthly imaging study. Arch Neurol (2008) 1.56
Intracytoplasmic tagging of cells with ferumoxides and transfection agent for cellular magnetic resonance imaging after cell transplantation: methods and techniques. Transplantation (2003) 1.55
Self-assembling nanocomplexes by combining ferumoxytol, heparin and protamine for cell tracking by magnetic resonance imaging. Nat Med (2012) 1.53
Craniotomy: true sham for traumatic brain injury, or a sham of a sham? J Neurotrauma (2011) 1.49
Paramagnetic viral nanoparticles as potential high-relaxivity magnetic resonance contrast agents. Magn Reson Med (2005) 1.48
Macromolecular MRI contrast agents for imaging tumor angiogenesis. Eur J Radiol (2006) 1.46
Evolution of T1 black holes in patients with multiple sclerosis imaged monthly for 4 years. Brain (2003) 1.43
In vitro model of bromodeoxyuridine or iron oxide nanoparticle uptake by activated macrophages from labeled stem cells: implications for cellular therapy. Stem Cells (2008) 1.41
Neurite beading is sufficient to decrease the apparent diffusion coefficient after ischemic stroke. Proc Natl Acad Sci U S A (2010) 1.40
Are radiation oncologists serious about systemic radiation therapy and if not, should we be? Int J Radiat Oncol Biol Phys (2004) 1.39
Detection of migration of locally implanted AC133+ stem cells by cellular magnetic resonance imaging with histological findings. FASEB J (2008) 1.36
Temporal dynamics of the BOLD fMRI impulse response. Neuroimage (2004) 1.28
Susceptibility gradient mapping (SGM): a new postprocessing method for positive contrast generation applied to superparamagnetic iron oxide particle (SPIO)-labeled cells. Magn Reson Med (2008) 1.28
Concurrent binding of anti-EphA3 antibody and ephrin-A5 amplifies EphA3 signaling and downstream responses: potential as EphA3-specific tumor-targeting reagents. Cancer Res (2005) 1.28
Viral capsids as MRI contrast agents. Magn Reson Med (2007) 1.28
Gadolinium-fullerenol as a paramagnetic contrast agent for cellular imaging. Invest Radiol (2006) 1.24
Cellular MRI and its role in stem cell therapy. Regen Med (2008) 1.23
Examining brain microstructure using structure tensor analysis of histological sections. Neuroimage (2012) 1.21
Superparamagnetic iron oxide nanoparticles labeling of bone marrow stromal (mesenchymal) cells does not affect their "stemness". PLoS One (2010) 1.20
Optimization and validation of FePro cell labeling method. PLoS One (2009) 1.19
In vivo MRI using positive-contrast techniques in detection of cells labeled with superparamagnetic iron oxide nanoparticles. NMR Biomed (2008) 1.17
Radioimmunotherapy of human colon carcinoma xenografts using a 213Bi-labeled domain-deleted humanized monoclonal antibody. Cancer Biother Radiopharm (2004) 1.15
Characteristics of a new MRI contrast agent prepared from polypropyleneimine dendrimers, generation 2. Invest Radiol (2003) 1.14
Macrophagic and microglial responses after focal traumatic brain injury in the female rat. J Neuroinflammation (2014) 1.14
In vivo transfer of intracellular labels from locally implanted bone marrow stromal cells to resident tissue macrophages. PLoS One (2009) 1.12
In Vivo Cellular Imaging for Translational Medical Research. Curr Med Imaging Rev (2009) 1.12
Magnetic tagging of therapeutic cells for MRI. J Nucl Med (2009) 1.11
Ultrashort T2* relaxometry for quantitation of highly concentrated superparamagnetic iron oxide (SPIO) nanoparticle labeled cells. Magn Reson Med (2009) 1.09
Supramolecular protein cage composite MR contrast agents with extremely efficient relaxivity properties. Nano Lett (2009) 1.08
Magnetic resonance imaging tracking of ferumoxytol-labeled human neural stem cells: studies leading to clinical use. Stem Cells Transl Med (2013) 1.07
Magnetic resonance imaging of labeled T-cells in a mouse model of multiple sclerosis. Ann Neurol (2004) 1.07
Rat model of metastatic breast cancer monitored by MRI at 3 tesla and bioluminescence imaging with histological correlation. J Transl Med (2009) 1.03
Angiogenesis in multiple sclerosis: is it good, bad or an epiphenomenon? J Neurol Sci (2004) 1.02
EPI-BOLD fMRI of human motor cortex at 1.5 T and 3.0 T: sensitivity dependence on echo time and acquisition bandwidth. J Magn Reson Imaging (2004) 1.00
Enhanced homing permeability and retention of bone marrow stromal cells by noninvasive pulsed focused ultrasound. Stem Cells (2012) 1.00
MR microscopy of magnetically labeled neurospheres transplanted into the Lewis EAE rat brain. Magn Reson Med (2003) 0.98
Biodistribution of a 153 Gd-folate dendrimer, generation = 4, in mice with folate-receptor positive and negative ovarian tumor xenografts. Invest Radiol (2002) 0.97
Effect of human stem cells labeled with ferumoxides-poly-L-lysine on hematologic and biochemical measurements in rats. Radiology (2005) 0.96
Imaging approaches for the study of cell-based cardiac therapies. Nat Rev Cardiol (2009) 0.96
Demyelinated neocortical lesions in marmoset autoimmune encephalomyelitis mimic those in multiple sclerosis. Brain (2005) 0.95
Differentiation of glioma and radiation injury in rats using in vitro produce magnetically labeled cytotoxic T-cells and MRI. PLoS One (2010) 0.93
Differential microstructure and physiology of brain and bone metastases in a rat breast cancer model by diffusion and dynamic contrast enhanced MRI. Clin Exp Metastasis (2011) 0.92
Imaging of spontaneous ventriculomegaly and vascular malformations in Wistar rats: implications for preclinical research. J Neuropathol Exp Neurol (2014) 0.91
Loss of interhemispheric inhibition in patients with multiple sclerosis is related to corpus callosum atrophy. Exp Brain Res (2006) 0.91
P22 viral capsids as nanocomposite high-relaxivity MRI contrast agents. Mol Pharm (2012) 0.91
In vivo and in vitro inhibition of pancreatic cancer growth by targeted alpha therapy using 213Bi-CHX.A"-C595. Cancer Biol Ther (2005) 0.90
Synthesis of superparamagnetic nanotubes as MRI contrast agents and for cell labeling. Nanomedicine (Lond) (2008) 0.90
In vivo detection of embryonic stem cell-derived cardiovascular progenitor cells using Cy3-labeled Gadofluorine M in murine myocardium. JACC Cardiovasc Imaging (2009) 0.90
Synthesis of Complexable Fluorescent Superparamagnetic Iron Oxide Nanoparticles (FL SPIONs) and Cell Labeling for Clinical Application. Adv Mater (2008) 0.90
Diffuse cortical atrophy in a marmoset model of multiple sclerosis. Neurosci Lett (2008) 0.89
Investigation of cellular and molecular responses to pulsed focused ultrasound in a mouse model. PLoS One (2011) 0.88
Effects of indomethacin on cerebral blood flow at rest and during hypercapnia: an arterial spin tagging study in humans. J Magn Reson Imaging (2002) 0.88
Monitoring stem cell therapy in vivo using magnetodendrimers as a new class of cellular MR contrast agents. Acad Radiol (2002) 0.86
Pulsed arterial spin labeling: comparison of multisection baseline and functional MR imaging perfusion signal at 1.5 and 3.0 T: initial results in six subjects. Radiology (2002) 0.85
The evolution of traumatic brain injury in a rat focal contusion model. NMR Biomed (2012) 0.84
MRI of mouse models of neurological disorders. NMR Biomed (2007) 0.84
Magnetically-labeled sensitized splenocytes to identify glioma by MRI: a preliminary study. Magn Reson Med (2007) 0.84
Pulsed focused ultrasound pretreatment improves mesenchymal stromal cell efficacy in preventing and rescuing established acute kidney injury in mice. Stem Cells (2015) 0.83
Rapid spectrophotometric technique for quantifying iron in cells labeled with superparamagnetic iron oxide nanoparticles: potential translation to the clinic. Contrast Media Mol Imaging (2012) 0.83
Cyclooxygenase-2 or tumor necrosis factor-α inhibitors attenuate the mechanotransductive effects of pulsed focused ultrasound to suppress mesenchymal stromal cell homing to healthy and dystrophic muscle. Stem Cells (2015) 0.82
Quantitative T2* imaging of metastatic human breast cancer to brain in the nude rat at 3 T. NMR Biomed (2010) 0.81
Fast T(2) relaxometry with an accelerated multi-echo spin-echo sequence. NMR Biomed (2010) 0.81
Effects of long-term hypoxia and pro-survival cocktail in bone marrow-derived stromal cell survival. Stem Cells Dev (2013) 0.81
Pharmacokinetics of a high-generation dendrimer-Gd-DOTA. Acad Radiol (2002) 0.80
The effect of interferon beta-1b on size of short-lived enhancing lesions in patients with multiple sclerosis. Expert Opin Biol Ther (2008) 0.79
Subcurative radiation significantly increases cell proliferation, invasion, and migration of primary glioblastoma multiforme in vivo. Chin J Cancer (2013) 0.79
Antiangiogenic therapy through copper chelation. Expert Opin Ther Targets (2003) 0.79
Enhanced stem cell tracking via electrostatically assembled fluorescent SPION-peptide complexes. Nanotechnology (2009) 0.78
Manganese G8 dendrimers targeted to oxidation-specific epitopes: in vivo MR imaging of atherosclerosis. J Magn Reson Imaging (2014) 0.78
Phase contrast MRI is an early marker of micrometastatic breast cancer development in the rat brain. NMR Biomed (2011) 0.78
Identifying tumor vascular permeability heterogeneity with magnetic resonance imaging contrast agents. Invest Radiol (2002) 0.77
β-PIX is critical for transplanted mesenchymal stromal cell migration. Stem Cells Dev (2012) 0.77
Imaging folate binding protein expression with MRI. Acad Radiol (2002) 0.77
Comparison of methods for obtaining longitudinal whole-brain magnetization transfer measurements. J Magn Reson Imaging (2002) 0.76
Sigma-2 receptor as potential indicator of stem cell differentiation. Mol Imaging Biol (2012) 0.76
Magnetically labeled glial cells as cellular MR contrast agents. Acad Radiol (2002) 0.76
Transferrin receptor expression in iron oxide-labeled mesenchymal stem cells. Radiology (2008) 0.75
Trifunctional conjugation reagents. Reagents that contain a biotin and a radiometal chelation moiety for application to extracorporeal affinity adsorption of radiolabeled antibodies. Bioconjug Chem (2002) 0.75
The role of nonconventional magnetic resonance imaging techniques in demyelinating disorders. Curr Neurol Neurosci Rep (2003) 0.75
Microscopic R2* mapping of reduced brain iron in the Belgrade rat. Ann Neurol (2002) 0.75
908 Real-time, Image-guided Convection-enhanced Delivery of Interleukin 13-PE38QQR to the Primate Brainstem. Neurosurgery (2005) 0.75